The Pathology Of Atherosclerosis Plaque Development And Plaque Responses To Medical Treatment

This research review explains how atherosclerosis—the hardening and narrowing of arteries that leads to heart attacks and strokes—develops over decades and how it responds to treatment. The process begins surprisingly early, often in the teenage years, and continues for about 50 years. It starts when cholesterol and other fats get trapped in artery walls, become damaged by oxidation, and trigger chronic inflammation. This creates fatty streaks that eventually grow into larger plaques that can rupture or block blood flow.

Several risk factors accelerate this process, including high blood pressure, smoking, diabetes, obesity, and genetic predisposition. Importantly, this disease pattern appears to be universal across all races, ethnicities, and geographic locations worldwide—only the speed of progression varies based on individual risk factors.

The encouraging finding is that atherosclerosis, once thought to be inevitably progressive, can be effectively treated and slowed. Clinical trials show that statin medications (cholesterol-lowering drugs) can favorably change plaque size, composition, and inflammatory activity. Even in people with advanced atherosclerosis, statins begin reducing clinical risk within just 4 months, and these benefits persist for many years.

For those focused on metabolic health and longevity, this research underscores that cardiovascular disease prevention should start early and that it's never too late to benefit from treatment. At VALIA Health, this evidence supports our comprehensive approach to cardiovascular risk assessment and management, including early intervention strategies and personalized treatment plans that can significantly alter the trajectory of this decades-long disease process.